1. Center for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University, Belfast, United Kingdom;
2. School of Clinical and Experimental Sciences, University of Southampton, National Institute for Health and Care Research (NIHR) Southampton Biomedical Research Center, Southampton, United Kingdom;
3. Manchester Academic Health Science Center and NIHR Manchester Biomedical Research Center, Manchester University Hospitals National Health Service (NHS) Foundation Trust, Manchester, United Kingdom;
4. Asthma UK and British Lung Foundation Partnership, London, United Kingdom;
5. Niche Science and Technology Ltd., Richmond, United Kingdom;
6. Genentech Inc., San Francisco, California;
7. Department of Respiratory Sciences, Institute for Lung Health and Leicester NIHR Biomedical Research Center, University of Leicester, Leicester, United Kingdom;
8. Gartnavel General Hospital, Glasgow and University of Glasgow, Glasgow, United Kingdom;
9. NHS Greater Glasgow and Clyde, Stobhill Hospital, Glasgow, United Kingdom;
10. University of Birmingham and Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom;
11. the Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, United Kingdom;
12. Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, the University of Manchester, Royal Brompton and Harefield Hospitals, London, United Kingdom;
13. Nottingham Respiratory NIHR Biomedical Research Center, University of Nottingham, Nottingham, United Kingdom;
14. University College Hospitals NHS Foundation Trust, London, United Kingdom;
15. 23andMe, Sunnyvale, California; and
16. Oxford Respiratory NIHR Biomedical Research Center, Nuffield Department of Medicine, the University of Oxford, Oxford, United Kingdom